Oncology & Cancer

FDA approves first-line therapy for peripheral T-cell lymphoma

(HealthDay)—The U.S. Food and Drug Administration on Friday expanded approval for the use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with specific types of peripheral ...

Oncology & Cancer

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency said Tuesday in a news ...

Diabetes

Diabetic nerve damage may increase energy needed for walking

A new study suggests that diabetes-related nerve damage (peripheral neuropathy) may reduce the amount of energy stored by the Achilles tendon during walking. The tendon connects the back of the heel to the calf muscles. This ...

Neuroscience

Discovery could lead to new therapies for diabetics

New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

page 5 from 9